SNCB

SNCB

Target · Synuclein family protein

SNCB Synuclein beta · Beta-synuclein

SNCB (synuclein beta, beta-synuclein) is a cytoplasmic member of the synuclein family that may function in neuronal plasticity. It has been linked to the regulation of SNCA aggregation and to protection of neurons from induced caspase activation. Browse Assay Genie's current range of SNCB research reagents below, or read on for the biology behind the target.

Cytoplasmic proteinSynuclein family memberFound in Alzheimer lesions
134 aa
Protein length
~14 kDa
Molecular weight
5q35.2
Gene locus
Synuclein
Protein family
Target information

What is SNCB (synuclein beta)?

SNCB, or beta-synuclein, belongs to a small family of proteins that inhibit phospholipase D2 and may function in neuronal plasticity. UniProt describes it as a non-amyloid component of senile plaques found in Alzheimer disease, and it could act as a regulator of the SNCA aggregation process. The SNCB protein is localised to the cytoplasm.

A protective role in neurons has also been described. SNCB protects neurons from staurosporine- and 6-hydroxy dopamine (6OHDA)-stimulated caspase activation in a p53/TP53-dependent manner. It also contributes to restoring the anti-apoptotic function of SNCA that is abolished by 6OHDA. This makes it a useful point of comparison with SNCA in studies of neuronal survival and protein aggregation.

The SNCB gene is classed by HGNC in the synuclein family and among microRNA protein coding host genes. According to the NCBI Gene summary, the encoded protein is abundant in lesions of patients with Alzheimer disease, and alternative splicing results in multiple transcript variants. A mutation in this gene was found in individuals with dementia with Lewy bodies, although UniProt notes that the protein is not found in the Lewy bodies associated with Parkinson disease. Mouse and rat orthologs are both named Sncb.

Alzheimer disease research

SNCB is abundant in lesions of patients with Alzheimer disease and is a non-amyloid component of senile plaques.

Protein aggregation studies

SNCB could act as a regulator of the SNCA aggregation process, making it relevant to synuclein aggregation biology.

Neuronal survival and apoptosis

SNCB protects neurons from staurosporine- and 6OHDA-stimulated caspase activation in a p53/TP53-dependent manner.

Lewy body dementia genetics

A mutation in the SNCB gene was found in individuals with dementia with Lewy bodies.

Background

SNCB frequently asked questions

What does SNCB do?

SNCB is a synuclein family protein that inhibits phospholipase D2 and may function in neuronal plasticity. It could regulate SNCA aggregation and protects neurons from staurosporine- and 6OHDA-stimulated caspase activation in a p53/TP53-dependent manner. It also helps restore the anti-apoptotic function of SNCA.

What other names and isoforms does SNCB have?

The HGNC name is synuclein beta, and UniProt names the protein beta-synuclein. No alternative gene symbols are listed. The NCBI Gene summary notes that alternative splicing results in multiple transcript variants. Check the datasheet of any product for its validated reactivity.

Is SNCB linked to disease and conserved in rodents?

SNCB is abundant in Alzheimer disease lesions, and a mutation in the gene was found in individuals with dementia with Lewy bodies. It is not found in Parkinson disease Lewy bodies. Mouse and rat both have an ortholog named Sncb.

Explore

Related targets

Other synuclein family members, neurodegeneration-related proteins and apoptosis regulators with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt Q16143; product specifications from Assay Genie datasheets.

SNCB Product listing